EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 390 filers reported holding EXELIXIS INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $44 | -99.6% | 8,400 | -16.0% | 0.00% | – |
Q3 2020 | $11,000 | -38.9% | 10,000 | +835.5% | 0.00% | -100.0% |
Q1 2020 | $18,000 | -57.1% | 1,069 | -81.8% | 0.00% | -50.0% |
Q4 2019 | $42,000 | -53.8% | 5,869 | -75.6% | 0.00% | -75.0% |
Q3 2019 | $91,000 | -60.3% | 24,073 | -45.5% | 0.01% | -63.6% |
Q2 2019 | $229,000 | +44.9% | 44,173 | +290.7% | 0.02% | +37.5% |
Q1 2019 | $158,000 | +532.0% | 11,305 | -7.9% | 0.02% | +700.0% |
Q4 2018 | $25,000 | -87.2% | 12,275 | -52.2% | 0.00% | -85.7% |
Q3 2018 | $195,000 | +2.6% | 25,700 | +47.3% | 0.01% | -6.7% |
Q2 2018 | $190,000 | -61.4% | 17,450 | -56.7% | 0.02% | -65.1% |
Q1 2018 | $492,000 | -21.0% | 40,295 | -7.8% | 0.04% | +72.0% |
Q4 2017 | $623,000 | -2.4% | 43,689 | -8.7% | 0.02% | +4.2% |
Q3 2017 | $638,000 | +46.0% | 47,844 | -34.2% | 0.02% | +50.0% |
Q2 2017 | $437,000 | +231.1% | 72,755 | -42.9% | 0.02% | +220.0% |
Q1 2017 | $132,000 | +18.9% | 127,400 | +135.5% | 0.01% | +25.0% |
Q4 2016 | $111,000 | -77.3% | 54,104 | -8.6% | 0.00% | -82.6% |
Q3 2016 | $489,000 | +3160.0% | 59,192 | +1016.8% | 0.02% | +2200.0% |
Q2 2016 | $15,000 | +275.0% | 5,300 | +211.8% | 0.00% | – |
Q1 2016 | $4,000 | -60.0% | 1,700 | -79.3% | 0.00% | – |
Q4 2015 | $10,000 | – | 8,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |